Please assess the completion status of the following clinical trial:

Trial Title: Perforator Vein Injection for Symptomatic Venous Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* • The subject must be \> 18 years of age, male or female~  * Subject must be willing and able to wear compression stockings~ * Subject must have refluxing perforating veins ≥ 3.0 mm in diameter at the calf level or distally in the affected leg.~ * Subject presents with ulceration or other symptoms of venous stasis including:~rash, swelling, pain, bleeding, recurrent cellulitis~• The subject must sign a written informed consent, prior to randomization, using a form that is approved by the local Institutional Review Board.~Exclusion Criteria:~* • Pregnancy~  * Known allergy to STS~ * Refusal to wear compression stocking~ * Untreated significant great or small saphenous reflux~ * Disseminated malignancy or other terminal condition where subject is expected to live less than 6 months.~ * Significant arterial disease (ABI \< .8)~ * Buergers disease~ * Acute superficial thrombophlebitis~ * Phlebitis migrans~ * Acute cellulitis~ * Clinical evidence of active local or systemic infection

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Observation (Type: NO_INTERVENTION): None
- Injection + Compression (Type: EXPERIMENTAL): None
- Compression (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).